Delivery Order SPE2DB24D1205-SPE2DB25FDAGQ
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,804.19 to AmerisourceBergen Drug Corp for the supply of Pioglitazone HCL 45 mg tablets (30-count units). This competitively awarded, firm fixed-price delivery order was executed on August 21, 2025, with an ultimate completion date of August 22, 2025, and represents a non-set-aside procurement. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania, where...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,669.15, is a Firm Fixed Price Delivery Order for the supply of Pioglitazone HCL 45 MG Tablets. The contract has an ultimate completion date of February 7, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the supply of 4,564,135,046 units of the pharmaceutical product Pioglitazone HCL 30 mg tablets. The award is valued at $3,561.31 and has a period of performance through April 2, 2024. This delivery order is issued under Amerisourcebergen Drug Corp's...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,136.43 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Pioglitazone HCL 45 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,335.47 firm fixed-price delivery order is for the supply of Pioglitazone HCL 30 mg tablets. The contract has an ultimate completion date of June 18, 2025. Amerisourcebergen Drug Corp also holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,265.39 firm fixed-price contract is for the supply of Pioglitazone HCL 45 mg tablets. The contract has an ultimate completion date of April 19, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- The Defense Logistics Agency awarded a $1,006.57 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 500 pioglitazone hydrochloride 30 mg tablets. The delivery order was issued under an existing prime vendor contract vehicle to provide pharmaceutical products and services to DLA and the Department of Defense. Performance will occur at Amerisourcebergen's facility located in Conshohocken, Pennsylvania, with all supplies to be delivered between September 6-7,...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $281.20 to Amerisourcebergen Drug Corporation for the supply of 90 pioglitazone hydrochloride 30 mg tablets. As a top-tier subcontractor to Amerisourcebergen Corporation, Amerisourcebergen Drug Corporation will fulfill the order from its facility in Conshohocken, Pennsylvania between September 27-28, 2023. The Defense Logistics Agency leverages strategic sourcing vehicles to procure pharmaceuticals and medical...
- The Defense Logistics Agency awarded a delivery order valued at $3,559.88 to AmerisourceBergen Drug Corp for Pioglitazone-Metformin 15-850 mg tablets (60-count supply). This firm fixed-price, competitively awarded contract was executed on July 29, 2025, with an ultimate completion date of July 30, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, and represents a standard transaction within the company's extensive federal medical...
- The Defense Logistics Agency awarded a $151,380 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4562252833 pioglitazone hydrochloride 45 mg tablets. Under this contract, Amerisourcebergen will deliver 30 tablets of the specified medication to an address in Conshohocken, Pennsylvania by September 21, 2023. The Defense Logistics Agency manages the global supply chain for the United States Department of Defense and its military services, suggesting this...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FDAGQDelivery Order
The Defense Logistics Agency awarded a $3,498.19 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Pioglitazone HCL 30 mg tablets (90-count units). This non-set-aside contract is scheduled for completion by September 10, 2025, with performance conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting federal medical supply requirements through AmerisourceBergen's established vendor relationship with the Defense Logistics Agency. This award is issued under AmerisourceBergen's Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive global pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, maintains a significant role in the federal medical supply chain, providing a broad portfolio of medications and medical commodities to support military and veteran healthcare systems. The firm's contract history demonstrates consistent capability to fulfill competitive federal pharmaceutical procurement requirements across multiple therapeutic domains and delivery scales.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 9/9/25 |